Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage

Journal of Neurosurgery

Volumn 109, Issue 1, 2008, Pages 38-43

  Kim, Grace H ^a   Kellner, Christopher P ^a   Hahn, David K ^a   Desantis, Brianna M ^a   Musabbir, Muhith ^a   Starke, Robert M ^a   Rynkowski, Michal ^a   Komotar, Ricardo J ^a   Otten, Marc L ^a   Sciacca, Robert ^a   Schmidt, J Michael ^a   Mayer, Stephan A ^a   Connolly Jr , E Sander ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Monocyte chemoattractant protein 1; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

CCL2 PROTEIN, HUMAN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; BLOOD; BRAIN VASOSPASM; CASE CONTROL STUDY; CEREBROSPINAL FLUID; COHORT ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; INTRACRANIAL ANEURYSM; MALE; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ADULT; AGED; CASE-CONTROL STUDIES; CHEMOKINE CCL2; COHORT STUDIES; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 48049086124     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/JNS/2008/109/7/0038     Document Type: Article

References (39)

1. Andersson PB, Perry VH, Gordon S: The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 42:201-214, 1991
2. Barone FC, Feuerstein GZ: Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19:819-834, 1999 (Pubitemid 30173383)
3. Beech JS, Reckless J, Mosedale DE, Grainger DJ, Williams SC, Menon DK: Neuroprotection in ischemia-reperfusion injury: an antiinflammatory approach using a novel broad-spectrum chemokine inhibitor. J Cereb Blood Flow Metab 21:683-689, 2001 (Pubitemid 32510456)
4. Cartier L, Hartley O, Dubois-Dauphin M, Krause KH: Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 48:16-42, 2005 (Pubitemid 40215781)
5. Chen Y, Hallenbeck JM, Ruetzler C, Bol D, Thomas K, Berman NE, et al: Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 23:748-755, 2003 (Pubitemid 36713680)
6. Colotta F, Borré A, Wang JM, Tattanelli M, Maddalena F, Polentarutti N, et al: Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol 148:760-765, 1992
7. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, et al: Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53:123-135, 2003 (Pubitemid 36801515)
8. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Shütt S, et al: Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 31:2971-2975, 2000
9. Fernandez A, Schmidt JM, Claassen J, Pavlicova M, Huddleston D, Kreiter KT, et al: Fever after subarachnoid hemorrhage. Risk factors and impact on outcome. Neurology 68:1013-1019, 2007 (Pubitemid 46569135)
10. Gaetani P, Tartara F, Pignatti P, Tancioni F, Rodriguez y Baena R, De Benedetti F: Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 20:337-342, 1998
11. Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, Wiessner C: Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 22:308-317, 2002 (Pubitemid 34203058)
12. Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14-20, 1968
13. Ingall TJ, Whisnant JP, Wiebers DO, O'Fallon WM: Has there been a decline in subarachnoid hemorrhage mortality? Stroke 20:718-724, 1989 (Pubitemid 19168113)
14. Johnston SC, Selvin S, Gress DR: The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 50:1413-1418, 1998 (Pubitemid 28240362)
15. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R: Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke 30:1396-1401, 1999 (Pubitemid 29296067)
16. Kikuchi T, Okuda Y, Kaito N, Abe T: Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res 17:106-108, 1995
17. Kim JS: Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 137:69-78, 1996
18. Kubota T, Handa Y, Tsuchida A, Kaneko M, Kobayashi H, Kubota T: The kinetics of lymphocyte subsets and macrophages in subarachnoid space after subarachnoid hemorrhage in rats. Stroke 24:1993-2001, 1993 (Pubitemid 23352734)
19. Lerch C, Yonekawa Y, Muroi C, Bjeljac M, Keller E: Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 5:85-92, 2006 (Pubitemid 44729632)
20. Losy J, Zaremba J: Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 32:2695-2696, 2001 (Pubitemid 33055326)
21. Macdonald RL, Wallace MC, Coyne TJ: The effect of surgery on the severity of vasospasm. J Neurosurg 80:433-439, 1994 (Pubitemid 24073003)
22. Mack WJ, Mocco J, Hoh DJ, Huang J, Choudhri TF, Kreiter KT, et al: Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. J Neurosurg 96:71-75, 2002 (Pubitemid 34229988)
23. Matz PG: Continued progress in predicting outcome after subarachnoid hemorrhage. Stroke 33:208-209, 2002
24. Mocco J, Mack WJ, Kim GH, Lozier AP, Laufer I, Kreiter KT, et al: Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 97:537-541, 2002 (Pubitemid 34994369)
25. Mocco J, Ransom ER, Komotar RJ, Schmidt JM, Sciacca RR, Mayer SA, et al: Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage. Neurosurgery 59:529-538, 2006
26. Nau R: [Pathophysiology of neuronal injury in bacterial meningitis: concepts and implications.] Neurologia 18:47-53, 2003 (Span)
27. Nimmerjahn A, Kirchhoff F, Helmchen F: Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318, 2005 (Pubitemid 40746128)
28. Onda H, Kasuya H, Takakura K, Hori T, Imaizumi T, Takeuchi T, et al: Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 19:1279-1288, 1999 (Pubitemid 30176457)
29. Provencio JJ, Vora N: Subarachnoid hemorrhage and inflammation: bench to bedside and back. Semin Neurol 25:435-444, 2005
30. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T: Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery 56:1082-1092, 2005
31. Rankine EL, Hughes PM, Botham MS, Perry VH, Felton LM: Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur J Neurosci 24:77-86, 2006 (Pubitemid 44050668)
32. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS: Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 136:1229-1233, 1990 (Pubitemid 20210321)
33. Rothoerl RD, Axmann C, Pina AL, Woertgen C, Brawanski A: Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 18:68-72, 2006 (Pubitemid 44491162)
34. Schuiling WJ, de Weerd AW, Dennesen PJ, Algra A, Rinkel GJ: The simplified acute physiology score to predict outcome in patients with subarachnoid hemorrhage. Neurosurgery 57:230-236, 2005
35. Sercombe R, Dinh YR, Gomis P: Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 88:227-249, 2002 (Pubitemid 34302973)
36. Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenheim JJ, et al: Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 144:3034-3038, 1990 (Pubitemid 20149476)
37. Webb DJ, Monge JC, Rabelink TJ, Yanagisawa M: Endothelin: new discoveries and rapid progress in the clinic. Trends Pharmacol Sci 19:5-8, 1998 (Pubitemid 28094083)
38. Weber KS, Nelson PJ, Grone HJ, Weber C: Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 19:2085-2093, 1999 (Pubitemid 29422239)
39. Zhou L, Azfer A, Niu J, Graham S, Choudhury M, Adamski FM, et al: Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ Res 98:1177-1185, 2006 (Pubitemid 43948104)